All posts tagged crizotinib

  • 7511985228_f25433830a_o

    NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer

    The New England Journal of Medicine reports positive results of a phase 1 clinical trial of the drug crizotinib against the subset of lung cancer marked by rearrangement of the gene ROS1.

Ross Camidge, MD, chief of the Lung Cancer program at
the University of Colorado Cancer Center, helped to enroll Rabinowitz
in the phase 1 trial of a new ALK inhibitor.
Camidge
Dandelion
Colorectal cancer cells like these may develop from some of the same gene alterations found in subsets of lung cancer
Camidge
Pills
Pills
camidge-basket_award
Lungs.Embroidered